$20,000,000+

$0 - $200,000

$1,000,000 - $5,000,000

$5,000,000 - $20,000,000

$200,000 - $1,000,000

Most Popular

series g

Seed

Series A

Pre-Seed

Series B

Undisclosed

Series C

Series D

Angel Round

late stage

Crowdfunding

venture

series e

growth

Debt Financing

Early Stage

series f

Grant

Later Stage

strategic round

funding

2001

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Moderna Inc. is a biotechnology company at the forefront of messenger RNA (mRNA) therapeutics and vaccines. With a focus on developing innovative drugs, Moderna utilizes mRNA technology to stimulate protein or antibody production within patient cells. Their diverse pipeline encompasses prophylactic vaccines, therapeutic vaccines, intratumoral immuno-oncology, localized therapeutics, and liver intracellular treatments. Leveraging their mRNA therapeutics platform, Moderna pioneers the development and production of human proteins, antibodies, and novel proteins for disease prevention, treatment, and cure. They are actively involved in infectious disease, rare liver disease, immuno-oncology, and cardiovascular disease therapeutics.

Moderna Series G

series-g

Montreal-based travel startup, Hopper, recently secured a notable $82 million financing, supported by impressive accomplishments. They hold the distinction of being the sole company capable of predicting future flight prices with 95% accuracy up to a year before departure. Hopper gathers an astounding five to eight billion airfare price quotes daily, boasts a user base exceeding 10 million, and achieves over $1 million in daily flight sales.

Hopper Series G

The largest database of pitch decks that raised Series G round

Filters

The largest database of pitch decks that raised Series G round

FiltersClear all

Filters